Nephrology
News
Older women with ESRD face higher mortality, compared with male counterparts
LOS ANGELES – Further investigations regarding sex-based differences in dialysis treatment are required.
Conference Coverage
Dr. Joseph Vassalotti: Cancer risk minimal with ARBs
PHILADELPHIA - "I've been telling everyone not to stop on their own," said the senior officer of the National Kidney Foundation.
News
Canagliflozin lowers kidney failure risk in T2D: CREDENCE
The SGLT2 inhibitor also cut cardiovascular events.
Renal Consult
When Can You Stop Dialysis?
Patients confronted with a diagnosis of kidney failure requiring dialysis inevitably want to know, “For how long?” Here’s the data on who might...
Renal Consult
When to Start Dialysis
When is the best time to start dialysis? Our expert reviews the data on early versus late initiation, based on the patient’s glomerular filtration...
News
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
Opinion
A couple of little known side effects of medications
The cause of one patient’s acidosis and the correct blood pressure medication for another patient.
Conference Coverage
CKD, and even dialysis, may not be barriers to pregnancy
Nephrologist urges colleagues to get a grip on how to counsel patients of child-bearing age.
News
Good news, bad news about HCV in kidney disease
While new drugs wipe out the virus, outbreaks are still hitting dialysis clinics.
Conference Coverage
DPP-4 drugs for diabetes may protect kidneys too
Mortality declined dramatically in patients with type 2 diabetes mellitus who took the medication over an average of 3 years.